Fresenius labeling mix-up of 200,000 syringes deemed a Class I by FDA
admin 9th January 2018 Uncategorised 0The FDA has decided that Fresenius Kabi’s retrieval of more than 200,000 mislabeled syringes rises to the level of a Class I recall. The recall comes at a sensitive time for the generic sterile injectables company, which also recently received an FDA warning letter for a plant that makes cancer drugs.
More: Fresenius labeling mix-up of 200,000 syringes deemed a Class I by FDA
Source: fierce